Science 37 (with Sanofi providing strategic guidance!) raised a mere $31m to enable ‘clinical trial access for anyone, anywhere, anytime’ using their technology platform for virtual trials (NORA).

Apparently bringing trial needs from investigator sites into patients homes.

Decentralising setup, decreasing costs and increasing recruitment.

Must be good?

May never see an actual patient then?

What about Quality and Safety?

NORA stands for Network Oriented Research Assistant, and brings research directly to patients in their own homes. It integrates telemedicine technology into the clinical research process, and supports end-to-end management of clinical trials. From the first steps of trial design, to connecting with patients at home.

>>>

http://www.fiercebiotech.com/cro/sanofi-helps-science-37-raise-31m-to-reimagine-clinical-trials